Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

April 13, 2026 |  

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

- PMLiVE

Explore how AI, advanced analytics, and expanding access to real-world data are transforming Medical Affairs into a more influential strategic function. This webinar, presented in partnership with the Medical Affairs Professional Society (MAPS), features Lori Klein, Partner and Medical & Scientific Affairs Practice Lead at Inizio Ignite, Putnam, leading a panel discussion with Nikheel Kolatkar, MD, MPH, Vice President, US Medical at Genentech, Sonal Bhatia, MD, MSc, Former Chief Medical Officer, and Carl de Luca Ph.D., Director of Medical Insights & Analytics, Medical Affairs Oncology, Regeneron Pharmaceuticals Inc.

Watch the recording here.

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

Making sense of Nutraceuticals in China

Published in eyeforpharma February 2017 by Marc Yates

Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research...

Women’s health in emerging markets

Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and...

Research Partnership has published a new Living with Lupus (SLE) market report for 2017

SLE is a progressive and debilitating disease which affects 5 million people worldwide.

PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...

Cool heads in a crisis?

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...